Ella Zomer

4.8k total citations · 2 hit papers
114 papers, 2.8k citations indexed

About

Ella Zomer is a scholar working on Economics and Econometrics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ella Zomer has authored 114 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Economics and Econometrics, 41 papers in Surgery and 25 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ella Zomer's work include Health Systems, Economic Evaluations, Quality of Life (43 papers), Lipoproteins and Cardiovascular Health (26 papers) and Pharmaceutical Economics and Policy (15 papers). Ella Zomer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (43 papers), Lipoproteins and Cardiovascular Health (26 papers) and Pharmaceutical Economics and Policy (15 papers). Ella Zomer collaborates with scholars based in Australia, United Kingdom and United States. Ella Zomer's co-authors include Danny Liew, Zanfina Ademi, Richard Ofori‐Asenso, Alice Owen, Sophia Zoungas, Ken Lee Chin, Ilana N. Ackerman, Andrea J. Curtis, Mark Tacey and Jenni Ilomäki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Ella Zomer

112 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults

2019 372 citations Richard Ofori‐Asenso, Ella Zomer et al. profile →
The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030

2019 326 citations Ilana N. Ackerman, Ella Zomer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ella Zomer Australia	27	854	718	492	488	436	114	2.8k
Zanfina Ademi Australia	25	810 0.9×	814 1.1×	397 0.8×	558 1.1×	379 0.9×	201	3.1k
Marie Therese Cooney Ireland	22	564 0.7×	394 0.5×	353 0.7×	1.0k 2.1×	366 0.8×	56	2.4k
Steven R. Erickson United States	30	371 0.4×	588 0.8×	572 1.2×	879 1.8×	400 0.9×	133	3.3k
Rhonda L. Bohn United States	28	695 0.8×	576 0.8×	469 1.0×	729 1.5×	205 0.5×	83	3.5k
Hsien‐Yen Chang United States	33	845 1.0×	613 0.9×	406 0.8×	430 0.9×	274 0.6×	103	4.0k
Yoshio N. Hall United States	31	438 0.5×	299 0.4×	266 0.5×	346 0.7×	434 1.0×	62	3.0k
Colin R. Dormuth Canada	35	763 0.9×	1.2k 1.7×	408 0.8×	547 1.1×	149 0.3×	115	4.3k
Chris L. Bryson United States	35	416 0.5×	700 1.0×	603 1.2×	1.2k 2.5×	387 0.9×	64	4.3k
Amanda R. Patrick United States	33	566 0.7×	1.0k 1.5×	339 0.7×	909 1.9×	143 0.3×	58	3.9k
Kristijan H. Kahler United States	27	480 0.6×	583 0.8×	309 0.6×	454 0.9×	163 0.4×	72	2.9k

Countries citing papers authored by Ella Zomer

Since Specialization

Citations

This map shows the geographic impact of Ella Zomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Zomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Zomer more than expected).

Fields of papers citing papers by Ella Zomer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella Zomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Zomer. The network helps show where Ella Zomer may publish in the future.

Co-authorship network of co-authors of Ella Zomer

This figure shows the co-authorship network connecting the top 25 collaborators of Ella Zomer. A scholar is included among the top collaborators of Ella Zomer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella Zomer. Ella Zomer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lloyd, Melanie, et al.. (2024). The productivity burden of breast cancer in Australia. Cancer Epidemiology. 94. 102726–102726. 1 indexed citations

Zomer, Ella, et al.. (2024). Is Semaglutide Cost-Effective for the Secondary Prevention of Cardiovascular Disease in People with Overweight or Obesity in Australia?. Heart Lung and Circulation. 33. S523–S523. 1 indexed citations

Hamblin, Peter S., Arul Earnest, Anthony Russell, et al.. (2024). Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023. Diabetes Obesity and Metabolism. 26(11). 4924–4932. 4 indexed citations

Abushanab, Dina, Daoud Al‐Badriyeh, Clara Marquina, et al.. (2024). The reduction of the productivity burden of cardiovascular disease by improving the risk factor control Among Australians with type 2 diabetes: a 10-year dynamic analysis. European Journal of Preventive Cardiology. 33(1). 121–131. 2 indexed citations

Marquina, Clara, Jedidiah I Morton, Tom Brett, et al.. (2023). Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment. Circulation Genomic and Precision Medicine. 16(3). 267–274. 2 indexed citations

Pease, Anthony, Emily Callander, Ella Zomer, et al.. (2022). The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth. Diabetes Care. 45(9). 1971–1980. 10 indexed citations

Pease, Anthony, Sophia Zoungas, Emily Callander, et al.. (2022). Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis. Diabetes Care. 45(11). 2611–2619. 6 indexed citations

Marquina, Clara, Stella Talic, Dina Abushanab, et al.. (2021). Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. European Journal of Preventive Cardiology. 29(8). 1212–1219. 44 indexed citations

Courten, Barbora de, Danny Liew, Zanfina Ademi, et al.. (2021). Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis. Diabetes Care. 44(3). 715–721. 14 indexed citations

10.

Zomer, Ella, YongJoo Rhee, Danny Liew, & Zanfina Ademi. (2021). The Health and Productivity Burden of Depression in South Korea. Applied Health Economics and Health Policy. 19(6). 941–951. 16 indexed citations

11.

Ademi, Zanfina, Ilana N. Ackerman, Ella Zomer, & Danny Liew. (2021). Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden. PharmacoEconomics. 39(3). 271–273. 33 indexed citations

12.

Liew, Danny, Zanfina Ademi, Alice Owen, et al.. (2021). The Impact of Diabetes on Productivity in India. Diabetes Care. 44(12). 2714–2722. 12 indexed citations

13.

Liew, Danny, et al.. (2020). The Health and Productivity Burden of Migraines in Australia. Headache The Journal of Head and Face Pain. 60(10). 2291–2303. 15 indexed citations

14.

Marquina, Clara, Ella Zomer, Cate Bailey, et al.. (2020). The economic impact of familial hypercholesterolemia on productivity. Journal of clinical lipidology. 14(6). 799–806.e3. 12 indexed citations

15.

Marquina, Clara, Ella Zomer, Sophia Zoungas, et al.. (2020). Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness. PharmacoEconomics. 38(10). 1095–1113. 31 indexed citations

16.

Zomer, Ella, et al.. (2020). Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis. PharmacoEconomics. 38(9). 1007–1020. 27 indexed citations

17.

Liew, Danny, et al.. (2020). Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis. Journal of clinical lipidology. 14(6). 772–783. 18 indexed citations

18.

Chowdhury, E., Christopher M. Reid, Ella Zomer, Darren J. Kelly, & Danny Liew. (2018). Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario. American Journal of Hypertension. 31(10). 1156–1163. 22 indexed citations

19.

Ofori‐Asenso, Richard, Ella Zomer, Andrea J. Curtis, et al.. (2017). Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review. JMIR Research Protocols. 6(3). e39–e39. 3 indexed citations

20.

Zomer, Ella, Andrew R. Kompa, Paul A. Komesaroff, & Henry Krum. (2006). Urotensin II is a vasoconstrictor in diabetic patients without heart failure or essential hypertension. European Heart Journal. 27. 532–532. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact